Who founded Scinvivo?

Scinvivo was founded by Marijn van Os, Diederik van Lierop in 2016.

Who are Scinvivo's investors?

Scinvivo's investors include NLC.

Where is Scinvivo headquartered?

Scinvivo is headquartered in Eindhoven, NL.

Scinvivo

Eindhoven, NL · Founded 2016 · 18 employees on LinkedIn · 3 known investors

Find your way into Scinvivo

Paths you didn't know you had: your email and LinkedIn already hold routes to the Scinvivo team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Scinvivo develops Lumante, a catheter-based optical coherence tomography (OCT) imaging platform for real-time, minimally invasive visualization and local staging of bladder cancer during cystoscopy. The system, aimed at urologists, has received FDA Breakthrough Device Designation and is in pre-clinical/clinical development.

Deep Tech Healthtech Medical Devices

Founders & leadership

Scinvivo was founded in 2016 by Marijn van Os and Diederik van Lierop.

Marijn van OsCo-founder & CEOMarijn van Os holds a PhD in mechanical engineering and previously worked at Royal Philips in technology and development management roles in the Netherlands and Czech Republic. He founded Innoluce in 2010 as a Philips spin-off focused on MEMS mirror technology, which was acquired by Infineon in 2016; he co-founded Scinvivo in 2016 and has served as its CEO since October 2019.

Diederik van LieropCo-founder, Software/Hardware DeveloperDiederik van Lierop is a co-founder and software/hardware developer at Scinvivo with a background in mechatronics and microelectromechanical systems (MEMS), including prior experience with MEMS mirrors, lidar, and automotive applications. He previously co-founded a startup that achieved a successful exit and has filed 27 patent applications, with 9 granted.

Maaike de JongCMO (Chief Medical Officer)Chief Medical Officer at Scinvivo, which develops an optical coherence tomography imaging platform for bladder cancer visualization during cystoscopy.

Camile van der HeijdenCTOCamile van der Heijden is CTO of Scinvivo, which develops Lumante, a catheter-based optical coherence tomography imaging platform for real-time visualization and staging of bladder cancer during cystoscopy.

Liesbeth GeertsCCOLiesbeth Geerts is Chief Commercial Officer at Scinvivo, which develops an optical coherence tomography imaging platform for bladder cancer visualization. She has over 20 years of experience in healthcare technology development and commercialization.

Maarten HaastCFOMaarten Haast is a CFO at Scinvivo with background as a senior consultant focused on mergers & acquisitions, financial systems implementation, supply chain optimization, and financial process design for international businesses.

Investors · 3

NLClisted by NLCAmsterdam

How we know: NLC's portfolio page · Not right? Tell us

Also in the syndicate · 2

Santec OIS CorporationThe NLC Health Impact fund

In the news

Scinvivo successfully closed a €4.7M investment round towards the market introduction of Scinvivo’s OCT platform - Scinvivoscinvivo.com · Feb 2024

Frequently asked questions

What does Scinvivo do?: Scinvivo develops Lumante, a catheter-based optical coherence tomography (OCT) imaging platform for real-time, minimally invasive visualization and local staging of bladder cancer during cystoscopy. The system, aimed at urologists, has received FDA Breakthrough Device Designation and is in pre-clinical/clinical development.
Who founded Scinvivo?: Scinvivo was founded by Marijn van Os, Diederik van Lierop in 2016.
Who are Scinvivo's investors?: Scinvivo's investors include NLC.
Where is Scinvivo headquartered?: Scinvivo is headquartered in Eindhoven, NL.